Columbia, Missouri 65212

  • Substance Use Disorders


Project STAR aims to examine the feasibility, acceptability, and initial efficacy of a CBT-I supplement to outpatient alcohol and substance use treatment.

Study summary:

Among those who receive treatment for alcohol use disorder (AUD), one in three relapses to problematic drinking within one year of treatment. Thus, additional treatment strategies are needed. Notably, up to 74% of individuals seeking treatment for AUD report co-occurring symptoms of insomnia, while 85% of those seeking SUD treatment report insomnia symptoms. Given the negative impact of insomnia on attention and emotion regulation, insomnia symptoms may decrease patients' abilities to attend to treatment for substance use and manage negative emotions that lead to craving and relapse. This project aims to examine the feasibility, acceptability, and initial efficacy of a CBT-I supplement to substance use treatment. Forty adults who meet diagnostic criteria for AUD or SUD and Insomnia Disorder will receive Cognitive Behavioral Therapy for Insomnia (CBT-I). In order to generate hypotheses regarding the efficacy of CBT-I for individuals who are and are not engaged in substance use treatment, we aim to recruit 20 participants who are engaged in substance use treatment through the community at baseline and 20 participants who are not. Outcomes will be assessed at the end of the active intervention period (6 weeks) and at 6 weeks post-intervention


Inclusion Criteria: - Participation in alcohol or substance use treatment in the Columbia, MO area - DSM-5 criteria for moderate to severe Alcohol Use Disorder of Substance Use Disorder - DSM-5 episodic criterion (duration at least 1 month) for Insomnia Disorder Exclusion Criteria: - unable to provide informed consent - cognitive impairment - continuous sobriety for 2+ months at baseline - untreated sleep disorder requiring more than behavioral treatment for insomnia - severe psychiatric disorder that requires immediate clinical attention - initiation of a sleep medication in the past six (6) weeks



Primary Contact:

Mary E Miller, PhD
Phone: 573-882-1813

Backup Contact:

Nicole A Hall, BA
Phone: 573-882-8598

Location Contact:

Columbia, Missouri 65212
United States

Mary Beth Miller, PhD
Phone: 573-882-1813

Site Status: Recruiting

Data Source:

Date Processed: August 03, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.